secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001628280-23-013333
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute receives Nasdaq delisting warning over bid price below $1.00
-------------------------------------------------------------------------------

- Nasdaq notified TOI on Apr 25, 2023 of non-compliance with minimum bid price rule (5450(a)(2)).
- Company has 180 calendar days, until Oct 23, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by Oct 23, may qualify for an additional 180-day period if meeting other listing standards.
- Company may seek stockholder approval for a reverse stock split to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000162828023013333/0001628280-23-013333-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000162828023013333/toi-20230425.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-013333

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer